CENTAUR PHARMACEUTICALS INC
10-Q, EX-27.01, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: CENTAUR PHARMACEUTICALS INC, 10-Q, EX-10.01, 2000-11-14
Next: SMITH BARNEY DIVERSIFIED FUTURES FUND LP, 10-Q, 2000-11-14



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM ITEM 1 OF
FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2000 AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          13,468
<SECURITIES>                                     6,946
<RECEIVABLES>                                    1,769
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                23,025
<PP&E>                                          15,590
<DEPRECIATION>                                   8,120
<TOTAL-ASSETS>                                  30,900
<CURRENT-LIABILITIES>                            4,504
<BONDS>                                          1,501
                                0
                                          0
<COMMON>                                            18
<OTHER-SE>                                      24,877
<TOTAL-LIABILITY-AND-EQUITY>                    30,900
<SALES>                                              0
<TOTAL-REVENUES>                                 6,118
<CGS>                                                0
<TOTAL-COSTS>                                 (15,844)
<OTHER-EXPENSES>                                   215
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 561
<INCOME-PRETAX>                                (9,479)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (9,479)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (9,479)
<EPS-BASIC>                                     (0.56)
<EPS-DILUTED>                                   (0.56)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission